Correlation Engine 2.0
Clear Search sequence regions


  • ALB (10)
  • albumin levels (1)
  • community (6)
  • factors (1)
  • female (1)
  • human (3)
  • patient (3)
  • pneumonia (6)
  • prognosis (6)
  • serum albumin (4)
  • Sizes of these terms reflect their relevance to your search.

    Community-acquired pneumonia (CAP) is a respiratory disease frequently requiring hospital admission, and a significant cause of death worldwide. This study aimed to investigate the prognostic value of clinical indicators. A prospective, multi-center study was conducted (January 2017-December 2018) where patient demographic and clinical data were recorded (N = 366). The 30-day mortality rate was 5.46%. Cox Regression analyses showed that serum albumin (ALB) and respiratory rate (RR) were independent prognostic variables for 30-day survival in patients with CAP. Albumin negatively correlated with the Pneumonia Severity Index (PSI) and CURB-65 scores using Pearson and Spearman tests. Survival curves showed that a RR >24 breaths/min or ALB ≤30 g/L were associated with a significantly higher risk of mortality. The area-under-the-curve (AUC) for predicting 30-day mortality in patients with CAP was 0.762, 0.763, 0.790, and 0.784 for ALB, RR, PSI, and CURB-65, respectively. The AUC for the prediction of 30-day mortality using ALB combined with PSI, CURB-65 scores, and RR was 0.822 (95% CI 0.731-0.912), 0.847 (95% CI 0.755-0.938), and 0.847 (95% CI 0.738-0.955), respectively. Albumin and RR were found to be reliable prognostic factors for CAP. This combination showed equal predictive value when compared to adding ALB assessment to PSI and CURB-65 scores, which could improve their prognostic accuracy.

    Citation

    Lili Zhao, Jing Bao, Ying Shang, Ying Zhang, Lu Yin, Yan Yu, Yu Xie, Li Chen, Yali Zheng, Yu Xu, Zhancheng Gao. The prognostic value of serum albumin levels and respiratory rate for community-acquired pneumonia: A prospective, multi-center study. PloS one. 2021;16(3):e0248002

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33662036

    View Full Text